MiscellaneousGlenmark to conduct ‘FAITH’ trials May 27, 2020May 30, 2020 - by Abdul Facts:FAITH trial is a randomised open study trial conducted by Glenmark Pharmaceuticals Ltd to test the combined efficacy of two antiviral drugs — Favipiravir and Umifenovir — as a potential COVID-19 treatment strategy. Print PDF
